landiolol has been researched along with Critical Illness in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M | 1 |
| Chalkias, A; O'Donnell, EP | 1 |
| Er, F; Gassanov, N | 1 |
| Ait-Oufella, H; Baudel, JL; Bige, N; Hariri, G; Mazerand, S; Urbina, T | 1 |
| Landoni, G; Monaco, F; Poveda-Jaramillo, R; Zangrillo, A | 1 |
3 review(s) available for landiolol and Critical Illness
| Article | Year |
|---|---|
Mechanisms of landiolol-mediated positive inotropy in critical care settings.
Topics: Adrenergic beta-Antagonists; Animals; Critical Care; Critical Illness; Heart Failure; Heart Rate; Humans; Urea | 2023 |
[The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Critical Illness; Humans; Morpholines; Propanolamines; Urea | 2019 |
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Critical Illness; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Perioperative Period; Propanolamines; Urea | 2018 |
2 other study(ies) available for landiolol and Critical Illness
| Article | Year |
|---|---|
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Topics: Child; Critical Illness; Female; Heart Rate; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Male; Retrospective Studies; Tachycardia; Tachycardia, Sinus; Urea; Ventricular Dysfunction | 2023 |
Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients.
Topics: Aged; Atrial Fibrillation; COVID-19 Drug Treatment; Critical Illness; Female; Heart Rate; Hospitalization; Humans; Intensive Care Units; Male; Morpholines; Patient Safety; Prospective Studies; Treatment Outcome; Urea | 2021 |